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rabbits, Intense bands of positive immunostalning for ADM was obsewed in 
the endothelial and immediate subendothellal regions, with minimal staining 
In underlying vascular smooth muscle. In contrast, the atherosclerotic aortas 
• demonstrated positive immunostalning in the vascular smooth muscle as 
well as in the atherosclarotic plaque, with a loss of endothelial staining in 
damaged ~ndothellum. The current study demonstrates for the flint time the 
presevme of immunoreactive ADM in the normal endothalium. Secondly, the 
studies also demonstrate the loss of endo'helial ADM immunoreaciivity in 
stbercsclerosis with markedly increased activity in the atherosclerotic plaque 
and undedying vascular smooth muscle in hypercholesterolerclc atheroscle- 
rosls. These studies support an important role for ADM in cardiovascular 
regulation and its potential aslivetlon in experimental therosclarosis, 
~ Polymorphisms in the Angiotensln I-Converting 
Enzyme and Apolipoprsfain E Genes and Late 
Luminal Narrowing After Coronary Angioplssty In 
Men 
Christian Moussard, Alaln Vuillemenot, Fmnqois Schieta, 
Nicolas Moneveau, Jean,Claude Henry, Jean-Pierre Bassand. University 
Hospital Resangon, FRANCE 
Poly..loqohisms in the angiotensin I-converting enzyme gane (ACE I/D} and 
upolipoprotoln E (ape E) may be I~nked to coronary heart disease, with re- 
spactively alleles D and e4 as dsk factor. Therefore we investigated the 
relationship between the ACt= I/D and upo E genatypes and the incidence 
of restenosls after coronary angiuptasty. Methods. Amplification of genomic 
DNA using polymerese chain reaction (PCR) and restriction enzyme frag- 
ment length polymorphisms (RFLP) yielded the ACE genotypos II, ID and 
DD, and Ape E ganotypas (e2e3, e3e3, e2e4, a3e4 and e4e4) in 91 male 
patients with CAD. Results. The frequency of the DD genotype was signifi- 
cantly higher among CAD patients than controls (38/91 = 0.42 versus3511~J 
= 0.29, p = 0.05). No significant difference in DD genotype frequency was 
found between patients with restenosls (defined as • 50% diameter alenesis 
at 6 months fcilow-up) and patients without restenosis (18/37 = 0.49 versus 
20/54 = 0.37, p = 0.27). Nevertheless D allele relative frequency was higher 
in pstients With restenosis (0.Tq versus 0.59, P = 0.09). The mean differ- 
ence in minimal coronary lume, diameter between post-PTCA and follow-up 
angiogram (late Io~) was no significantly different in the 3 groups of ACE 
genotypa. The relative e4 allele frequency was higher among CAD patients 
than controls (0.16 versus 0.10, p = 0.05). The distributions of ape E gano- 
types or alleles in restenosis group was not significantly different from that 
of the ncn-restenosls group. Late loss was similar in patient with or without 
allele e4 in their genotype. In conclusion, Pclymoqohlsm In the angiatensin 
I-converting enzyme and apolipoprotein E genes had no influence on the 
occursnca of restenosis after coronary ecgioplasty. 
D Polymorphism ot the Anglotensln Convert ing 
Enzyme Gene Is Strongly ASsociated Wllh the 
Development of  Physiological Left Ventricular 
Hypertrophy 
Hugh Montgomery, Peter Ctarkson, Clare Dollery, Krishna Prosed, 
Made-Angola Losl, Deborah Stattere, Mick Jubb 1, Jean McEwan, 
Stephen Humphdes, William McKenca. UCL and St George's Medical 
Schools, London, UK; ~ RAMC Mi//bank, London, UK 
The I/D polymorphlsm of the anglotsnsln-conveding enzyme (ACE) gene 
comprises the presence (insertion allele, I) or absence (deletion allele, D) 
of a 297 base pair fragment. The D allele is associated with higher clr- 
culstlng (and possibly tissue) ACE levels. We tested the hypothesis that 
ranln-anglotsnsin systems control myocardial growth, by examining the influ- 
ence of ACE genolypa on physiological left ventr/cuMr hypertrophy. Method 
and Results: ACE genatypa was determined in 154 male British Army re- 
cmits. B.nstluretlc peptlde(BNP) levels (a hormone whose levels are linked 
to LV mass) and echooardlngraphlsally-determlned posterior wall(PW) and 
septet hickness (ST) and left ventdcular mass(LVM) were measured at the 
start and end of 10 weeks of intensive physical training. All measures of LV 
hypertrophy were associated strongly with the D allele (table shows changes 
in all parameters: p for heterogeneity < 0.001: < 0.08 t) 
I! ID DD 
ST (mm) -0.03 0.08 0.14" 
PW (mm) -0.03 0.08 0.13" 
LVM (g) -1.27 47.2 56.9" 
L ..Vl~Nheight (g/cm) -0.01 0.27 0.32* 
BNP levels ross by 40%, 64=/0 and 180% respectively (p < 0.01). 
Conclusions: Left ventricular growth in response to exercise is strongly 
determined by ACE ganotype. This finding has important implications con- 
cerning the rote of renln-angtotensln systems in pathuphyslologlcal LVH. 
Serum Autcenl lbodles Against  G-Protein 
Coupled Receptors In Myocardial  Diseases 
Shlnohu MatsuI, Michael Fu ~, Tomoyukl Hirakawa, Kohal Teranka, 
Mitanru Hayase, Noberu Takskashl, ElJi MurakamL Kanazawa Mad'col 
University, Japan; 1 C~teborg University,, Sweden 
There is an increasing evidence for the participation of cellular and humorel 
autoimmunlty in the pathngenasls of various myocardial ¢~isaeses. The pur- 
pose of this study was to assess the pathophysiotoglcal role of autoantibod- 
tes against G-preteln coupled receptors in myocarditis(MC), dilsted(DCM) 
One hypedrophic(HCM) cardlomyopathy. Five poptides corresponding to the 
sequences of the second extracellular loops of the human ~1-, 82, el ,  
mussadnic chdiinergtc(M,?.) and angtotensln-II(AII) receptors were used as 
antigens in an enzyme immunoassay to screen ~era from patients with MC(N 
= 18), DCM(n = 28), HCM(n = 23) and the age-matched healthy blood donor 
(HBD)(n = 23). 
[Results] Detection of autoantibodies by ELISA. 
~81 ,82 al M2 All 
DCM(n = 28) 9 (32%)** 2 (7%) 4 (14%) 10 (36%)" 1 {4%) 
MC(n= 18) 6(33%) "° 2(11%) 3(17%) 2(11%) 3(17%) 
HCM(n=23) 3(13%) 1 (4%) 2 (6%) 5(22%) 0 (0%) 
HBD(n-23) 2 (9%) 2 (6%) 2 (9%) 3(13%) 3(13%) 
""p .,: 0.05, "p < 0.1 vs. HBD 
[Conclusion] A subgroup of patients with DCM and mycoarditis have au- 
tcantibodias pecifically directed against the second ext~caltutar loops o! 
the ~1 and/or M2 receptors. These autoantibedies (anti-,at and anti M2) 
could play an important role in pathogenesis of myocard{tis and DCM. These 
findings also indicate that the evolution of DCM alter myoca~lls might be 
predominantly due to an autolmmune mechanism. 
~ Incrsased Frequency o f  the Deletion Allele of  the 
ACE Gene in Afr ican-Americans Compared to 
Caucasians 
Baxter D. Montgomery, Elizabeth A. Putnam, John Reveille, Dianna 
M. Mifewicz. The University of Texas Health Science Center at Houston, TX 
The inse:tion/daletion (I/D) DNA polymorphlsm of the anglatensln converting 
enzy~,o (ACE) gone has been studied in patients with heart disease. The 
DD ganotypo has been found to be associated with increased left ventricutar 
mass (LVM) independent of syststlc or diastolic blood pressure (BP). African- 
Ameflcans have more left vantricular hypertrophy (LVH) than Cs,.~casPane with 
equivalent BR The D allele has been found at a frequency of approximately 
50% in studies of Caucasian populations. We compared the frequency of the 
D allele in the above populations. We hypothesize that the frequency of the 
D allele will be increased among Afdcan-Americans(AA) as it may explain 
a genetic contribution to the increase frequency of LVH among African. 
Americans. Methods: Genomic DNA was harvested from peripheral blood 
leukocytes obtained from 29 unrelated, healthy Affican-Amarlcans and 29 
Caucasians. The gonatypo f the ACE gone was determined b.v DCR using 
the ganomic DNA samples and standard pdmers and condition~. 
Results: 
Populations I allele (%) D allele (%) p value 
AA 15 (26%) 43 (14%) .,:0.05 
Caucasians 27 (47%) 31 (52%) 
Conclusions: The frequency of the D allele Is significantly increased In 
the population of Afdcan-Ameticans compared to Caucasians. These data 
suggest that a possible genellc contribution to the increased incidence of 
LVH found in the population of AfdcanoAmedcans. 
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~ C o s t  Avoidance Through Early Discharge of  the 
Uncomplicated Acute Myocardial  Infarction Patient 
Eric L. Elsensteln, L Kflstin Newby, J. David Knight, Leslee J. Shaw, Robed 
M. Catiff, Eric J. Topoi, Daniel B. Mark. Duke University Medical Center, 
Durham, NC 
Analysis of GUSTO-I data has shown that uncomplicated acute myocardial 
infarction (UCMI) patients (without ralnfarctlon, ischemta, stroke, shock, head 
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failure (Killtp dass > 1 ), death, bypass surgery, balloon pumping, emergency 
cath, cardioversion, or defibrillation) can be discharged safely as eady as 
four days after the acute evenL 53.3% of the 22,043 US GUSTO-I patients 
for whom we had resource utilization data met the UCMI critada. For these 
patients, we calculated potential cost savings (hospital and physician) from 
early discharge (day 4) and found that they averaged $4,201 (26.5°/= of total 
costs). 
Observed Data Early Discharge 
Category Compt M! UCMt UCMI Reduction 
LOS 10.6 8.9 4.0 55.1% 
Room Cast 
Regular $3,686 $3,355 $562 83,2% 
ICU 12,760 6,900 5,492 20.4% 
Procedures 7,484 4,961 4,961 0.0% 
Othar Cost 652 609 609 0.0% 
Total Cost $24,582 $15,825 $11,624 26.5% 
Note: all non-zero reductions have a p < 0.01 
Conclusion: One fourth of all costs of treating uncomplicated acute MI 
patients may be avoided if dlnioal criteda are used to stratify these patients 
for early discharge (day 4). 
i '~"~ Utilization end Outcomes In Cardiac Perlusion 
Imaging: Are Physicians Sincere? 
Dennis R Human, Derrick Blackmore, UItian X. Cluett, Michael Hoskinsen, 
Terrenca J. Montegue, University of Alberta, Edmonton, Canada 
Cardiac perfusion imaging is a widely used investigation i coronary heart 
disease (CHD) with acceptable diagnostic discrimination. Inan atmosphere 
of diminishing resources expensive diagnostic moralities must entrain ef- 
fective outcomes to ha considered appropriate. We gathered prospective 
data at the time of patient referral to determine whether physicians reliably 
pursued their pretest intended clinical course post.test, and examined the 
test outcome with ultimate resource alloc~.zion. Methods: Beginning in Oct. 
1993 810 consecutive patients were enrolled and followed until Aug. 1995. 
The study group consisted of 258 women and 552 men with a mean age 
of 59.5 years. Those having CHD referred for risk etrati~¢.ation comprised 
the majority (438); 272 were referred for diagnosis. All had an intermediate 
pretest probability of ischamla. Most patients had MIBI imaging utilizing a 2 
day protocol; some had thallium. Images were Interpreted W consensus of 2 
observers and classified as normal; abnormm, iow risk; and, zdonom'ml, high 
risk. Hospital databases and charts were audited to determine clinical out- 
come classified as conservative, invesive and death. Results:Normal scans 
were found in 326 patients, all of whom were pmpased in this case to have a 
conservative course. Only 19 came to subsequent invasive management and 
there were 2 deaths. Abnormal, low risk scans were found in 232 patients; 
23 came to invasive management; 1 died. High risk scans were found in 190 
patients in whom prospectively, the physician planned invesive management 
but accomplished this in only 122 with 6 deaths (Chl-square p < 0.0001). 
Conclusions: Pedusion scans appear cost-effective in the clinical settinq Of 
CHD diagnosis and dsk stratification by avoiding expansive invasive xam- 
inations in patients at low risk and directing effective thera~w to those who 
may benefit the most. Physicians are sincere in adhering to guidelines et 
for themselves. 
[~7"~'~ Does "ll'eatment Concordance With 
Revasculeflzatlon Apprepflateness Score Predict 
Long Term Outcome? A Comparison of RAND 
Panel Ratings, ACCIAHA GuldeUnse, and the 
University of Maryland Revascularlzatlon 
Appreprletenese Score (RAS) 
Gregory G. Bishop, Michael A. Lauer, Robert A. Vogel, Andrew A. Ziskind. 
University of Maryland, Baltimore, Maryland 
Despite the increasing use of guidelines for revascu/arization appropdate- 
ness, no data exist documenting their ability to predict clinical outcome. We 
prospectively studied 153 pts referred to the U. of MD oath lab to assess 
the ability of these scoring systems to predict outcome when the treatment 
delivered was concordant or discordant with the appropdatenass rating. 
The study population was 65% male, mean age 59 ± 12 ym, with diagnoses 
of unstable angina (n = 46), stable angina (39), acute MI (10), post-MI 
(40), asymptomatic with + ETT (16), and near sudden death (2). Follow- 
up was obtained on 98°/, with a mean f/u of 15.2:1:7.3 rues. Treatment 
consisted of PTCA (93), CABG (27), and medical therapy (33). For all pts, 
the appropriateness ratings for PTCA and CABG were determined by the 
RAND, ACC/AHA, and RAS systems using a scripted relational database. 
Treatment was considered iscordant if: 1.) the pt was revascularized and 
RAND, ACC/AHA and RAS ranked the lot as Inagpropdate, class III, or 
inappropriate r spectively, or 2.) the pt was not revascularized and the ratings 
were appmpdete &crucial, class I, or necessary. 
123 adverse events were seen in 76 pts: cardiac death 9, non-cardiac 
death 4, MI 7, revascularization 33, pemistent or recurrent angina 58, CHF 
12. RAND predicted revascalarization (p< 0,01). ACC/AHA prer;ioted mor- 
tality (13 = 0.02). RAS predicted both mortality (p = 0.02) and revascutarization 
(p < 0.01). For RAND and ACC/AHA major adverse outcomes were asso- 
ciated with failure to provide necessary revascularization. For RAS, major 
adverse outcomes were associated with both failure to provide necessary 
revasculadzation an well as the per to~ of inappropriate r vascu/arlza- 
lion. 
Conclusion: RAND, ACC/AHA and RAS scoring systems differ in their 
ability to predict adverse outcomes and in the specific outcomes they predict. 
.C.lase.ifl _catLon and Regression Trees (CART) 
modem to Delineate Use of Angiogrephy and 
Revasculm',zation After Thrombolysis for  Acute 
Myocerdla ~, infarction 
Louise Pilete, Dave P. Miller, Robert M. Caiiff, Eric J. Topoi for the GUSTO 
Investigators, C/eve/and Clinic Foundation, C/eve/and, OH 
Factors affecting the use of coronary angingraphy (anglo) and revascu~-- 
izetien after acute MI have not been clearly identified, We applied CART 
methodology to the GUSTO-I dataset o identify determinants of the uses of 
anglo, revaSCularizatton procedure and angioplasly (PTCA) versus bypass 
surgery (CABG). Among the 21,772 US GUSTO-I patients, 15,676 (72%) 
undemmnt angio before discharge. Of those, 9,249 (59%) underwent revas- 
cularlza~n (76% PTCA, 30=/. CABG). In the model on the use of anglo, age 
was the most determinant variable. Patients > 77 years old had only a 43% 
chance of undergoing anglo versus a 75% chance in those < 77 years. In the 
older age group, age was again the classifying variable. In contrast, in the 
younger age group, avallr.bility of PICA was the classifying variable. Only 
66% of those presenting at sites without PTCA received anglo versus 82% 
of patients at sites with PTCA. Recurrent Ischernia came alter availability of 
PTCA and was more important among patients at sites without PTCA (83°/= 
use among those with ischemia versus 62% among those without ischemia) 
than at sites with PTCA (90% versus 80%). CART models of PTCA and 
CABG use identified comnory anatomy as the predominant factor in the use 
and choice of procedure. Thus, in clinical practice, age and on-site availability 
of ~I'CA are the predominant factors leading to the decision to undergo an- 
glo. Once angfo is performed, however, the coronary anatomy largely drives 
the use and type of revescula, tzation procedures. 
Leveling the Playing Reid in Outcomes 
Comparisons: Patient Versus Medical Record Data 
Unda K. Shaw, Elizabeth R. DeLong, Eric D, Paterson, James G. Jollis, S. 
Robert Collins, Daniel B, Mark. Duke University, Durham, NC 
Statistical models can be used in outcomes cemparisen studies to "level 
the playing field." However. current models are based on physician (MD) or 
medical record data, which are often difficult and expensive to obtain. We 
developed amodel for prediction of signit'cant COronary disease (CAD) (> = 
75% stonosis in > = 1 coronary artery) based completely on data obtainable 
by patient (Pt) survey and compared its accuracy to a full model based on 
MD history, exam, and 12-lead ECG data. The models were developed in 
6,582 patients with chest pain refereed to Duke for cardiac catheterization. 
Important predictors included cardiovascular risk factors (hx of smoking, 
hypertension, diabetes, hypefl ip~ia, family hx of CAD, and PVD), demo- 
graphios (age, race, gender, height), and symptom description (pain qual- 
ifiers, hx of MI). When compared to the full model that included EKG and 
lab date, the Pt-based model showed negl~'ble degradation In predictive 
accuracy due to the absence of these variables. These results are shown 
below. 
Model x 2 df Area under ROC curve 
Pt data only 1415 13 0.827 
Pt + ECG + lab data 1498 15 0.834 
The Pt-basad model was validated in an independent catheritzation popu- 
lation (n = 628S) at Duke and achieved an ROC area of 0.85. 
Condus/en: This study shows that accurate statistical mede]s needed for 
adjustment in outcomes comparisons can be developed using only data 
obtainable directly from patients. 
